Urinary Hydration Markers Tested for Storage Condition Validity
By LabMedica International staff writers Posted on 27 Aug 2019 |

Image: The 3320 osmometer used to assess urine osmolality, a measure of urine concentration and hydration (Photo courtesy of Advanced Instruments).
Fluid balance is an aspect of the homeostasis of organisms in which the amount of water in the organism needs to be controlled, via osmoregulation and behavior, such that the concentrations of electrolytes in the various body fluids are kept within healthy ranges.
The human kidneys will normally adjust to varying levels of water intake. The kidneys will require time to adjust to the new water intake level. This can cause someone who drinks a lot of water to become dehydrated more easily than someone who routinely drinks less. Analysis of urine specimens is widely utilized to determine day-to-day hydration status in individuals as well as for other markers of health.
Scientists at the University of North Carolina at Greensboro (Greensboro, NC, USA) enrolled eight males and 13 females (mean ± SD; age, 24 ± 5 years; body mass, 68.9 ± 24.2 kg; height, 160.2 ± 32.1 cm) without a history of renal disease or currently taking any medications or supplements known to affect the accuracy of urinary hydration markers. Participants provided a 24 hour urine sample in a clean container with each urine sample being separate into four separate containers, two in each of the following temperatures: 7 °C and 22 °C. One specimen container at each temperature was either sealed using the manufacturers cap (single sealed, SS) or the manufacturers cap plus laboratory wrapping film (double sealed, DS).
Each sample was analyzed after 1, 2, 3, 7 and 10 days. Urine samples were assessed for urine osmolality (UOSMO), urine specific gravity (USG), and urine color (UCOL). UOSMO was stable at 7 °C for two days and three days for single sealed and double sealed containers, respectively. UOSMO was determined via freezing point depression with a 3320 osmometer. USG was measured using an optical refractometer that was accurate to ±0.001 AU and had a resolution of 0.0001. UCOL was measured by comparing each urine sample to an 8-point urine color chart where the sample was held against a white background in a well-lit room.
The team reported that USG measures were stable for singled sealed and double sealed for up to ten days when stored at 22 °C. UCOL measures were maintained for up to three days in all storage methods. For refrigerated samples, UOSMO measures for samples stored in SS containers became significantly elevated three days following baseline measures, whereas UOSMO measures for samples stored in DS containers became significantly elevated seven days following baseline measures. Conversely to UOSMO, USG measures were significantly elevated in SS and DS samples stored at 7 °C beginning one day following baseline measures, compared to SS and DS samples stored at 20 °C.
The authors concluded that to achieve optimal results, it is recommended that 24-hour urine samples are assessed immediately for the respective hydration markers being analyzed. If immediate analysis is unavailable, such as in the case of field based or longitudinal research, it is recommended that 24-hour urine samples are stored in a refrigerated environment and hydration markers (UOSMO and UCOL) be assessed within 48 hours. The study was published on August 5, 2019, in the journal PLOS ONE.
Related Links:
University of North Carolina at Greensboro
The human kidneys will normally adjust to varying levels of water intake. The kidneys will require time to adjust to the new water intake level. This can cause someone who drinks a lot of water to become dehydrated more easily than someone who routinely drinks less. Analysis of urine specimens is widely utilized to determine day-to-day hydration status in individuals as well as for other markers of health.
Scientists at the University of North Carolina at Greensboro (Greensboro, NC, USA) enrolled eight males and 13 females (mean ± SD; age, 24 ± 5 years; body mass, 68.9 ± 24.2 kg; height, 160.2 ± 32.1 cm) without a history of renal disease or currently taking any medications or supplements known to affect the accuracy of urinary hydration markers. Participants provided a 24 hour urine sample in a clean container with each urine sample being separate into four separate containers, two in each of the following temperatures: 7 °C and 22 °C. One specimen container at each temperature was either sealed using the manufacturers cap (single sealed, SS) or the manufacturers cap plus laboratory wrapping film (double sealed, DS).
Each sample was analyzed after 1, 2, 3, 7 and 10 days. Urine samples were assessed for urine osmolality (UOSMO), urine specific gravity (USG), and urine color (UCOL). UOSMO was stable at 7 °C for two days and three days for single sealed and double sealed containers, respectively. UOSMO was determined via freezing point depression with a 3320 osmometer. USG was measured using an optical refractometer that was accurate to ±0.001 AU and had a resolution of 0.0001. UCOL was measured by comparing each urine sample to an 8-point urine color chart where the sample was held against a white background in a well-lit room.
The team reported that USG measures were stable for singled sealed and double sealed for up to ten days when stored at 22 °C. UCOL measures were maintained for up to three days in all storage methods. For refrigerated samples, UOSMO measures for samples stored in SS containers became significantly elevated three days following baseline measures, whereas UOSMO measures for samples stored in DS containers became significantly elevated seven days following baseline measures. Conversely to UOSMO, USG measures were significantly elevated in SS and DS samples stored at 7 °C beginning one day following baseline measures, compared to SS and DS samples stored at 20 °C.
The authors concluded that to achieve optimal results, it is recommended that 24-hour urine samples are assessed immediately for the respective hydration markers being analyzed. If immediate analysis is unavailable, such as in the case of field based or longitudinal research, it is recommended that 24-hour urine samples are stored in a refrigerated environment and hydration markers (UOSMO and UCOL) be assessed within 48 hours. The study was published on August 5, 2019, in the journal PLOS ONE.
Related Links:
University of North Carolina at Greensboro
Latest Technology News
- Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
- Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
- Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
- Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
- Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
- Smartphones Could Diagnose Diseases Using Infrared Scans
- Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
- 3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
- POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
- Study Explores Impact of POC Testing on Future of Diagnostics
- Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
- Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears
- Lab-On-Chip Platform to Expedite Cancer Diagnoses
- Biosensing Platform Simultaneously Detects Vitamin C and SARS-CoV-2
- New Lens Method Analyzes Tears for Early Disease Detection
- FET-Based Sensors Pave Way for Portable Diagnostic Devices Capable of Detecting Multiple Diseases
Channels
Molecular Diagnostics
view channel
Microbial Cell-Free DNA Test Accurately Identifies Pathogens Causing Pneumonia and Other Lung Infections
Bronchoalveolar lavage (BAL) is a commonly used procedure for diagnosing lung infections, especially in immunocompromised patients. However, standard tests often fail to pinpoint the exact pathogen, leading... Read more
Non-Biopsy Approach to Transform Adult Celiac Disease Diagnoses
In the United States, the diagnosis of celiac disease in adults typically relies on a combination of serologic testing and a confirmatory small bowel biopsy during upper endoscopy. In contrast, European... Read moreHematology
view channel
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read more
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
New Blood Test Detects Up to Five Infectious Diseases at POC
Researchers have developed a prototype flow-through assay capable of detecting up to five different infections, with results that can be quickly analyzed and transmitted via a specialized smartphone app.... Read more
Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, led to 1.25 million deaths in 2023, with 13% of those occurring in people living with HIV. The current primary diagnostic method for... Read morePathology
view channel
Groundbreaking Chest Pain Triage Algorithm to Transform Cardiac Care
Cardiovascular disease is responsible for a third of all deaths worldwide, and chest pain is the second most common reason for emergency department (ED) visits. With EDs often being some of the busiest... Read more
AI-Based Liquid Biopsy Approach to Revolutionize Brain Cancer Detection
Detecting brain cancers remains extremely challenging, with many patients only receiving a diagnosis at later stages after symptoms like headaches, seizures, or cognitive issues appear. Late-stage diagnoses... Read moreTechnology
view channel
Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more